ITUA20161799A1 - Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale - Google Patents

Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale

Info

Publication number
ITUA20161799A1
ITUA20161799A1 ITUA2016A001799A ITUA20161799A ITUA20161799A1 IT UA20161799 A1 ITUA20161799 A1 IT UA20161799A1 IT UA2016A001799 A ITUA2016A001799 A IT UA2016A001799A IT UA20161799 A ITUA20161799 A IT UA20161799A IT UA20161799 A1 ITUA20161799 A1 IT UA20161799A1
Authority
IT
Italy
Prior art keywords
cisteamine
salt
pharmaceutical composition
prolonged release
release including
Prior art date
Application number
ITUA2016A001799A
Other languages
English (en)
Inventor
Andrea Gazzaniga
Matteo Cerea
Marco Barchielli
Alessandra Maroni
Original Assignee
Recordati Ind Chimica E Farmaceutica S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Ind Chimica E Farmaceutica S P A filed Critical Recordati Ind Chimica E Farmaceutica S P A
Priority to ITUA2016A001799A priority Critical patent/ITUA20161799A1/it
Priority to JP2018548115A priority patent/JP2019508441A/ja
Priority to ES17712937T priority patent/ES2879810T3/es
Priority to PCT/EP2017/055964 priority patent/WO2017157922A1/en
Priority to EA201891860A priority patent/EA201891860A1/ru
Priority to US16/084,308 priority patent/US11135173B2/en
Priority to EP17712937.6A priority patent/EP3429565B1/en
Priority to MX2018011293A priority patent/MX2018011293A/es
Priority to BR112018068155-5A priority patent/BR112018068155A2/pt
Priority to KR1020187030123A priority patent/KR102361246B1/ko
Priority to AU2017234169A priority patent/AU2017234169B2/en
Priority to CA3013429A priority patent/CA3013429A1/en
Priority to UAA201809212A priority patent/UA123782C2/uk
Publication of ITUA20161799A1 publication Critical patent/ITUA20161799A1/it
Priority to IL261087A priority patent/IL261087B/en
Priority to CONC2018/0009543A priority patent/CO2018009543A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITUA2016A001799A 2016-03-18 2016-03-18 Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale ITUA20161799A1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ITUA2016A001799A ITUA20161799A1 (it) 2016-03-18 2016-03-18 Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale
MX2018011293A MX2018011293A (es) 2016-03-18 2017-03-14 Composicion farmaceutica de liberacion prolongada que comprende cisteamina o sal de la misma.
BR112018068155-5A BR112018068155A2 (pt) 2016-03-18 2017-03-14 composição farmacêutica de liberação prolongada que compreende cisteamina ou sais da mesma
PCT/EP2017/055964 WO2017157922A1 (en) 2016-03-18 2017-03-14 Prolonged release pharmaceutical composition comprising cysteamine or salt thereof
EA201891860A EA201891860A1 (ru) 2016-03-18 2017-03-14 Фармацевтическая композиция пролонгированного высвобождения, содержащая цистеамин или его соли
US16/084,308 US11135173B2 (en) 2016-03-18 2017-03-14 Prolonged release pharmaceutical composition comprising cysteamine or salt thereof
EP17712937.6A EP3429565B1 (en) 2016-03-18 2017-03-14 Prolonged release pharmaceutical composition comprising cysteamine or salt thereof
JP2018548115A JP2019508441A (ja) 2016-03-18 2017-03-14 システアミンまたはその塩を含む持効性放出医薬組成物
ES17712937T ES2879810T3 (es) 2016-03-18 2017-03-14 Composición farmacéutica de liberación prolongada que comprende cisteamina o una sal de ella
KR1020187030123A KR102361246B1 (ko) 2016-03-18 2017-03-14 시스테아민 또는 이의 염을 포함하는 서방형 약학적 조성물
AU2017234169A AU2017234169B2 (en) 2016-03-18 2017-03-14 Prolonged release pharmaceutical composition comprising cysteamine or salt thereof
CA3013429A CA3013429A1 (en) 2016-03-18 2017-03-14 Prolonged release pharmaceutical composition comprising cysteamine or salt thereof
UAA201809212A UA123782C2 (uk) 2016-03-18 2017-03-14 Фармацевтична композиція пролонгованого вивільнення, що містить цистеамін або його солі
IL261087A IL261087B (en) 2016-03-18 2018-08-09 A pharmaceutical composition of cysteamine or a salt thereof with delayed release
CONC2018/0009543A CO2018009543A2 (es) 2016-03-18 2018-09-12 Composición farmacéutica de liberación prolongada que comprende cisteamina o sal de la misma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A001799A ITUA20161799A1 (it) 2016-03-18 2016-03-18 Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale

Publications (1)

Publication Number Publication Date
ITUA20161799A1 true ITUA20161799A1 (it) 2017-09-18

Family

ID=56203798

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A001799A ITUA20161799A1 (it) 2016-03-18 2016-03-18 Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale

Country Status (15)

Country Link
US (1) US11135173B2 (it)
EP (1) EP3429565B1 (it)
JP (1) JP2019508441A (it)
KR (1) KR102361246B1 (it)
AU (1) AU2017234169B2 (it)
BR (1) BR112018068155A2 (it)
CA (1) CA3013429A1 (it)
CO (1) CO2018009543A2 (it)
EA (1) EA201891860A1 (it)
ES (1) ES2879810T3 (it)
IL (1) IL261087B (it)
IT (1) ITUA20161799A1 (it)
MX (1) MX2018011293A (it)
UA (1) UA123782C2 (it)
WO (1) WO2017157922A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201609940D0 (en) * 2016-06-07 2016-07-20 Novabiotics Ltd Microparticles
IT201700064875A1 (it) * 2017-06-12 2018-12-12 Sicit 2000 Spa Sistemi multistrato idrorepellenti a rilascio controllato di principi attivi in acqua e nel terreno.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101653426A (zh) * 2009-09-16 2010-02-24 冯利萍 一种高稳型半胱胺盐酸盐的缓释小丸及制备方法
US8026284B2 (en) * 2006-01-27 2011-09-27 The Regents Of The University Of California Enterically coated cystamine, cysteamine and derivatives thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050004075A1 (en) * 2000-12-13 2005-01-06 Walcom Animal Science (I.P.2) Limited Composition for regulating animal growth, method of manufacture and use thereof
JP4966665B2 (ja) * 2003-11-19 2012-07-04 オメガ バイオ−ファーマ （アイ．ピー．１） リミテッド アルコール代謝を改善し、二日酔いの影響を軽減するための材料と方法
SI1880718T1 (sl) * 2006-07-10 2011-11-30 Pfleger R Chem Fab Farmacevtski pripravki za oralno dajanje z nadzorovanim sproščanjem zdravila v majhne intestinke kolone in postopek njihove priprave
DK2214480T3 (da) * 2007-11-30 2013-07-08 Univ California Fremgangsmåder til behandling af nonalkoholisk steatohepatitis (NASH) ved anvendelse af cysteaminprodukter
MX2012007448A (es) 2009-12-22 2012-09-12 Abbott Healthcare Private Ltd Composicion farmaceutica de liberacion controlada.
KR20140125644A (ko) * 2013-04-19 2014-10-29 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 레프리젠티드 바이 더 세크러터리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비스즈 종양 전이의 저해에 있어서의 시스테아민 및 그의 유도체의 용도
AR096628A1 (es) * 2013-06-17 2016-01-20 Raptor Pharmaceuticals Inc Formulación en perlas de cisteamina de liberación retardada y métodos de preparación y uso de ella

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8026284B2 (en) * 2006-01-27 2011-09-27 The Regents Of The University Of California Enterically coated cystamine, cysteamine and derivatives thereof
CN101653426A (zh) * 2009-09-16 2010-02-24 冯利萍 一种高稳型半胱胺盐酸盐的缓释小丸及制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 201021, Derwent World Patents Index; AN 2010-C52531, XP002763913 *

Also Published As

Publication number Publication date
BR112018068155A2 (pt) 2019-02-12
JP2019508441A (ja) 2019-03-28
EA201891860A1 (ru) 2019-02-28
AU2017234169A1 (en) 2018-08-16
AU2017234169B2 (en) 2023-01-12
US11135173B2 (en) 2021-10-05
CO2018009543A2 (es) 2018-10-10
IL261087A (en) 2018-10-31
IL261087B (en) 2021-10-31
WO2017157922A1 (en) 2017-09-21
KR20180120268A (ko) 2018-11-05
UA123782C2 (uk) 2021-06-02
US20190076368A1 (en) 2019-03-14
EP3429565B1 (en) 2021-06-09
EP3429565A1 (en) 2019-01-23
KR102361246B1 (ko) 2022-02-09
ES2879810T3 (es) 2021-11-23
CA3013429A1 (en) 2017-09-21
MX2018011293A (es) 2019-02-13

Similar Documents

Publication Publication Date Title
DK3529248T3 (da) Farmaceutiske sammensætninger
NO2024007I1 (no) Elacestrant or a salt thereof
DK3536380T3 (da) Hurtigtvirkende insulinsammensætninger
DK3233108T3 (da) Hurtigtvirkende insulinsammensætninger
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
DK3529240T3 (da) Farmaceutiske forbindelser
DK3554534T3 (da) Farmaceutisk sammensætning omfattende insulin
ES2969514T3 (es) Composición farmacéutica de liberación sostenida
DK3474858T3 (da) Tokomponentsammensætning omfattende acetylsalicylsyre
BR112016030507A2 (pt) Compostos relacionados à vitamina d, composição farmacêutica, e kit
ITUA20161799A1 (it) Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale
DK3089740T3 (da) Farmaceutisk sammensætning
FR3023934B1 (fr) Mecanisme d&#39;horlogerie
DK3728220T3 (da) Farmaceutiske forbindelser
IT201600122469A1 (it) Composizione farmaceutica solida a prova di abuso
UA35584S (uk) Ювелірний виріб «оберіг»
UA34698S (uk) Ювелірна прикраса «хлопчик-пряник»
UA31754S (uk) Етикетка для цукерок «chocolatier»
DK3581582T3 (da) Farmaceutisk forbindelse
UA33076S (uk) Етикетка «шпатлевка магнезиальная»
UA33117S (uk) Підвіска «коловрат свєточ»
UA29855S (uk) Цукерка «вареник»
UA31742S (uk) Емблема «бмк»
BR112017004882A2 (pt) composição farmacêutica oral.
UA31772S (uk) Етикетка «воронеж»